jagomart
digital resources
picture1_Plastic Pdf 116589 | File622


 162x       Filetype PDF       File size 2.82 MB       Source: ncdc.gov.in


File: Plastic Pdf 116589 | File622
national treatment guidelines for antimicrobial use in infectious diseases version 1 0 2016 national centre for disease control directorate general of health services ministry of health family welfare government of ...

icon picture PDF Filetype PDF | Posted on 05 Oct 2022 | 3 years ago
Partial capture of text on file.
      
      
                      
                                        
              National Treatment Guidelines 
       for Antimicrobial Use in Infectious Diseases 
                                                       
                                    
                               Version 1.0 (2016) 
                                    
                                    
                                    
                                    
                   NATIONAL CENTRE FOR DISEASE CONTROL 
                       Directorate General of Health Services 
                        Ministry of Health & Family Welfare 
                             Government of India 
                                      
                                      
                                      
                                      
                                    
       
      
                              CONTENTS 
     Chapter 1 .................................................................................................................................................................................................................. 7 
      Introduction ........................................................................................................................................................................................................ 7 
     Chapter 2. ................................................................................................................................................................................................................. 9 
      Syndromic Approach For Empirical Therapy Of Common Infections.......................................................................................................... 9 
       A. Gastrointestinal & Intra-Abdominal Infections ......................................................................................................................................... 10 
       B. Central Nervous System Infections ........................................................................................................................................................... 13 
       C. Cardiovascular Infections .......................................................................................................................................................................... 14 
       D. Skin & Soft Tissue Infections ................................................................................................................................................................... 15 
       E. Respiratory Tract Infections ...................................................................................................................................................................... 16 
       F. Urinary Tract Infections ............................................................................................................................................................................. 17 
       G. Obstetrics And Gynaecological Infections ................................................................................................................................................ 18 
       H. Bones And Joint Infections ....................................................................................................................................................................... 22 
       I.  Eye Infections ............................................................................................................................................................................................ 23 
       J.  Ear Infections ............................................................................................................................................................................................ 25 
       K. Infections in Burn and Plastic Surgery ...................................................................................................................................................... 26 
       L.  Fungal Infections ...................................................................................................................................................................................... 27 
       M. Febrile Neutropenia .................................................................................................................................................................................. 27 
       N. Post-Cardiovascular Surgery Infections .................................................................................................................................................... 29 
       O. Pediatric Infections ................................................................................................................................................................................... 31 
       P. Neonatal Infections .................................................................................................................................................................................... 39 
       R. Post Solid Organ Transplant ...................................................................................................................................................................... 40 
       S. Surgical Antimicrobial Prophylaxis ........................................................................................................................................................... 41 
     Chapter 3 ................................................................................................................................................................................................................ 42 
      Treatment Of Muti-Drug Resistant Bacterial Pathogens .............................................................................................................................. 42 
       1. Methicillin- Resistant S. aureus (MRSA) .................................................................................................................................................. 42 
       2. Vancomycin  Resistant  Enterococcus  (VRE) ........................................................................................................................................... 42 
       3. Extended Spectrum Βeta-Lactamases (ESBL) Producing Enterobacteriaceae. .......................................................................................... 42 
       4. Carbapenem- Resistant Enterobacteriaceae (CRE) .................................................................................................................................... 42 
     Chapter 4 ................................................................................................................................................................................................................ 44 
      Guidelines For Optimizing Use Of Key Antimicrobials ................................................................................................................................ 44 
       A.  Antimicrobial Prescribing: Good Practice ................................................................................................................................................ 44 
       B.  Reserve Antimicrobials ............................................................................................................................................................................ 45 
       C.  Hypersensitivity ....................................................................................................................................................................................... 45 
       D. Alert Antimicrobials.................................................................................................................................................................................. 46 
       E. Alert Antibiotics And Their Indications .................................................................................................................................................... 46 
     Chapter 5 ................................................................................................................................................................................................................ 49 
      Preventive Strategies For Healthcare Associated Infections ......................................................................................................................... 49 
       A. Healthcare Associated Infections .............................................................................................................................................................. 49 
       B. Reducing the risk of Health care associated infections.............................................................................................................................. 49 
     Chapter 6 ................................................................................................................................................................................................................ 50 
      Monitoring Antimicrobial Use ......................................................................................................................................................................... 50 
       A. Background ............................................................................................................................................................................................... 50 
       B. Need For Surveillance To Track Antimicrobial Use And Resistance ....................................................................................................... 50 
       C. Standardized Methodology And Outcome Measures ................................................................................................................................ 50 
       D. Situation In Developing Countries ............................................................................................................................................................ 51 
       High-end Antibiotic Monitoring Sheet .......................................................................................................................................................... 52 
       Surgical Prophylaxis Monitoring Sheet ......................................................................................................................................................... 52 
     Chapter 7 ................................................................................................................................................................................................................ 53 
      Dosage Guide For Commonly Used Antimicrobial Agents ........................................................................................................................... 53 
     Chapter 8 ................................................................................................................................................................................................................ 57 
      Link To National Programme Current Guidelines For Treatment Of Specific Infections......................................................................... 57 
     Chapter 9 ................................................................................................................................................................................................................ 59 
      Case Definitions And Diagnosis For Common Infections .................................................................................................................................. 59 
       DIARRHEA ................................................................................................................................................................................................... 59 
       ENTERIC FEVER ......................................................................................................................................................................................... 59 
       SPONTANEOUS BACTERIAL PERITONITIS ........................................................................................................................................... 59 
       ACUTE PANCREATITIS ............................................................................................................................................................................. 59 
       ACUTE BACTERIAL MENINGITIS ........................................................................................................................................................... 60 
       BRAIN ABSCESS ......................................................................................................................................................................................... 60 
       INFECTIVE ENDOCARDITIS ..................................................................................................................................................................... 60 
       CELLULITIS ................................................................................................................................................................................................. 61 
       FURUNCULOSIS ......................................................................................................................................................................................... 61 
       URINARY TRACT INFECTIONS ............................................................................................................................................................... 61 
       PNEUMONIA ............................................................................................................................................................................................... 61 
     ABBREVIATIONS ................................................................................................................................................................................................ 63 
                      
                                                             2 
      
                                                       3     
     
                                                  4 
     
The words contained in this file might help you see if this file matches what you are looking for:

...National treatment guidelines for antimicrobial use in infectious diseases version centre disease control directorate general of health services ministry family welfare government india contents chapter introduction syndromic approach empirical therapy common infections a gastrointestinal intra abdominal b central nervous system c cardiovascular d skin soft tissue e respiratory tract f urinary g obstetrics and gynaecological h bones joint i eye j ear k burn plastic surgery l fungal m febrile neutropenia n post o pediatric p neonatal r solid organ transplant s surgical prophylaxis muti drug resistant bacterial pathogens methicillin aureus mrsa vancomycin enterococcus vre extended spectrum eta lactamases esbl producing enterobacteriaceae carbapenem cre optimizing key antimicrobials prescribing good practice reserve hypersensitivity alert antibiotics their indications preventive strategies healthcare associated reducing the risk care monitoring background need surveillance to track resist...

no reviews yet
Please Login to review.